Chronotherapy of hypertension: advantages of 48-h ambulatory blood pressure monitoring assessments in MAPEC and Hygia Chronotherapy Trial

References

• Association AD. 2017. Standards of Medical Care in Diabetes – 2017. Diabetes Care. 40(suppl 1):S11–S24. doi:10.2337/dc17-S005.
   PubMedGoogle Scholar
• Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC. on behalf of the Hygia Project Investigators. 2013. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 30:99–115. doi:10.3109/07420528.2012.701489.
   PubMed Web of Science ®Google Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. 2007. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension. 49:1235–1241. doi:10.1161/HYPERTENSIONAHA.107.087262.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, et al. 2007. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 370(9594):1219–1229. doi:10.1016/S0140-6736(07)61538-4.
   PubMed Web of Science ®Google Scholar
• Bowles NP, Thosar SS, Herzig MX, Shea SA. 2018. Chronotherapy for hypertension. Curr Hypertens Rep. 20(11):97. doi:10.1007/s11906-018-0897-4.
   PubMed Web of Science ®Google Scholar
• Calvo C, Hermida RC, Ayala DE, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. 2003. The “ABPM effect” gradually decreases but does not disappear in successive sessions of ambulatory monitoring. J Hypertens. 21:2265–2273. doi:10.1097/01.hjh.0000084799.73547.45.
   PubMed Web of Science ®Google Scholar
• Charlson ME, de Moraes CG, Link A, Wells MT, Harmon G, Peterson JC, Ritch R, Liebmann JM. 2014. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 121(10):2004–2012. doi:10.1016/j.ophtha.2014.04.016.
   PubMed Web of Science ®Google Scholar
• De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 24(8):698–706. doi:10.1016/j.ejim.2013.03.019.
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. 2005. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 46(1):156–161. doi:10.1161/01.HYP.0000170138.56903.7a.
   PubMed Web of Science ®Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. 2013. Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 30(1–2):17–30. doi:10.3109/07420528.2012.715872.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. 2008. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 51(1):55–61. doi:10.1161/HYPERTENSIONAHA.107.100727.
   PubMed Web of Science ®Google Scholar
• Fan H-Q, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, et al. 2010. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 28(10):2036–2045. doi:10.1097/HJH.ob013e32833b49fe.
   PubMed Web of Science ®Google Scholar
• Hermida RC. 2007. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int. 24:749–775. doi:10.1080/07420520701535837.
   PubMed Web of Science ®Google Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia Project. Chronobiol Int. 33(7):906–936. doi:10.1080/07420528.2016.1181078.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. 2016. Ambulatory blood pressure, chronotherapy of hypertension and glaucoma. Med Clin. 146(1):30–34. doi:10.1016/j.medcli.2015.05.013.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. 2013a. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 30(1–2):176–191. doi:10.3109/07420528.2012.701131.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. 2013b. Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30(1–2):280–314. doi:10.3109/07420528.2012.709448.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. 2011a. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens. 24(4):383–391. doi:10.1038/ajh.2010.217.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013c. Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67. doi:10.3109/07420528.2012.701457.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27(8):1629–1651. doi:10.3109/07420528.2010.510230.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011b. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58(11):1165–1173. doi:10.1016/j.jacc.2011.04.043.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2013d. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – the “normotensive non-dipper” paradox. Chronobiol Int. 30(1–2):87–98. doi:10.3109/07420528.2012.701127.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39(5):277–292. doi:10.1007/s00125-015-3748-8.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. 2002. Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J Am Coll Cardiol. 40(4):710–717. doi:10-1016/s0735-1097(02)02011-9.
   Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2019. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. Epub ahead of print. doi:10.1093/eurheartj/ehy754
   Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39(47):4159–4171. doi:10.1093/eurheartj/ehy475.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Mojón A, for the Hygia Project Investigators. 2020a. Chronotherapy of hypertension, asleep ambulatory blood pressure, and glaucoma. Eur Heart J. 41(16):1605–21605. doi:10.1093/eurheartj/ehaa215
   PubMed Web of Science ®Google Scholar
• Hermida RC, Fernández JR, Mojón A. 2020b. Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial. Chronobiol Int. In press
   Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR. 2020c. for the Hygia Project Investigators. bedtime hypertension chronotherapy best reduces cardiovascular disease risk as documented by MAPEC and Hygia chronotherapy outcomes trials. Chronobiol Int. In press
   Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013e. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410. doi:10.3109/07420528.2013.750490.
   PubMed Web of Science ®Google Scholar
• Israel S, Israel A, Ben-Dov IZ, Bursztyn M. 2011. The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Am J Hypertens. 24(7):796–801. doi: 10.138/ajh.2011.58.
   Google Scholar
• JN I IIB, Jaeger BC, Huang L, Abdalla M, Sims M, Butler M, Muntner P, Shimbo D. 2020. Morning blood pressure surge and cardiovascular disease events and all-cause mortality in blacks: the Jackson Heart Study. Hypertension. 75:835–842. doi:10.1161/HYPERTENSIONAHA.119.14233.
   Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. 2003. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 107(10):1401–1406. doi:10.1161/01.CIR.0000056521.67546.AA.
   PubMed Web of Science ®Google Scholar
• Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. 2013. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 1: definition and classification of CKD. Kidney Int Suppl. 3:19–62. doi:10.1038/kisup.2012.64.
   Web of Science ®Google Scholar
• Lemmer B, Middeke M. 2020. A commentary of the Spanish hypertension studies MAPEC and Hygia. Chronobiol Int. In press doi:10.1080/07420528.2020.1761374.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. 2009. A new equation to estimate glomerular filtration rate. Ann Intern Med. 150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, et al. 2011. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 57(20):2020–2028. doi:10.1016/j.jacc.2010.11.022.
   PubMed Web of Science ®Google Scholar
• Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. 2006. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline. The Ohasama study. Hypertension. 47(2):149–154. doi:10.116110.1161/01.HYP.0000198541.12640.0f.
   Google Scholar
• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, et al. 2011. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 171:1090–1098. doi:10.1001/archinternmed.2011.230.
   PubMed Web of Science ®Google Scholar
• Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC. on behalf of the Hygia Project Investigators. 2013. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 30:145–158. doi:10.3109/07420528.2012.703083.
   PubMed Web of Science ®Google Scholar
• Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, et al. 2018. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 34(5):506–525. doi:10.1016/j.cjca.2018.02.022.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189. doi:10.1097/00004872-200211000-00017.
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. 2015. Diagnosis and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 162:192–204. doi:10.7326/M14-1539.
   Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16(2):151–166. doi:10.3109/07420528.2010.510788.
   PubMed Web of Science ®Google Scholar
• Rana S, Prabhu SD, Young ME. 2020. Chronobiological influence over cardiovascular function. The Good, the Bad, and Ugly. Circulation Res. 126:258–279. doi:10.1161/CIRCRESAHA.119.313349.
   PubMed Web of Science ®Google Scholar
• Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC. on behalf of the Hygia Project Investigators. 2013. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol Int. 30:207–220. doi:10.3109/07420528.2012.701135.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014a. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–2340. doi:10.1097/HJH.0000000000000355.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. 2014b. Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16:561–568. doi:10.1111/jch.12354.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:10.1161/HYPERTENSIONAHA.115.06981.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. 2015. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des. 21:756–772. doi:10.2174/1381612820666141024130013.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. 2015. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 21:773–790. doi:10.2174/1381612820666141024150542.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. 2010. Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 15:173–180. doi:10.1097/MBP.0b013e32833c7308.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. 2007. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680. doi:10.1016/j.sleep.2006.11.011.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16. doi:10.1016/j.smrv.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Sole MJ, Martino TA. 2009. Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol. 107(4):1318–1327. doi:10.1152/japplphysiol.00426.2009.
   PubMed Web of Science ®Google Scholar
• Sothern RB, Vesely DL, Kanabrocki EL, Hermida RC, Bremner FW, Third JLHC, Boles MA, Nemchausky BM, Olwin JH, Scheving LE. 1995. Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol Int. 12:106–120. doi:10.3109/07420529509064506.
   PubMed Web of Science ®Google Scholar
• Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. 2015. Treatment of hypertension with chronotherapy: is it time? Ann Pharmacother. 49(3):323–334. doi: 10.1177/1060028014563535.
   PubMed Web of Science ®Google Scholar
• Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. 2004. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 48:380–385. doi:10.1007/s10384-003-0071-6.
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, et al. 2019. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 42:1235–1481. doi:10.1038/s41440-019-0284-9.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, Ambrosio G, Reboldi G. 2012. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension. 60(1):34–42. doi:10.1161/HYPERTENSIONAHA.112.191858.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, et al. 1994. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 24:793–801. doi:10.1161/01.hyp.24.6.793.
   PubMed Web of Science ®Google Scholar
• Werne A, Harris A, Moore D, BenZion I, Siesky B. 2008. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol. 53(6):559–567. doi:10.1016/j.survophthal.2008.08.021.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmerfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 71:e127–e248. doi:10.1016/j.jacc.2017.11.006.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/EHS Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39:3021–3104. doi:10.1093/eaurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu P, Wan C, Wang Z. 2011. Evening versus morning dosing regimen drug therapy for hypertension. The Cochrane Database of Systematic Reviews. 10:CD004184. doi:10.1002/14651858.CD004184.pub2.
   Google Scholar